Premium
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
Regulatory News: This replaces the announcement made at 1:56 PM CEST on May 3 due to the following corrections: "Exercise of stock options and warrants" instead of "Exercise of stock options...
Regulatory News: Eurofins (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11...
Q1 2022 revenues of €1,760m, +9.1% vs. Q1 2021, despite a significant decrease in COVID related revenues Q1 2022 total revenue organic growth2 of +1.1% vs. Q1 2021, impacted by the reduction in...
Regulatory News: Eurofins Scientific SE (Paris:ERF): ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal...
Regulatory News: EUROFINS SCIENTIFIC SE (Paris:ERF): Les actionnaires de la Société, et uniquement avec voix consultative les porteurs de Deeply Subordinated Fixed to Floating Rate Bonds (ISIN...
Eurofins (Paris:ERF): Eurofins Genomics wird Our Future Health, das bislang größte Gesundheitsforschungsprogramm des Vereinigten Königreichs, unterstützen. Dazu wird Eurofins Genomics fünf...
Eurofins (Paris : ERF) : Eurofins Genomics est fier d'annoncer son soutien à Our Future Health, le plus grand programme de recherche en santé jamais mis en place au Royaume-Uni. Eurofins...
Eurofins (Paris:ERF): Eurofins Genomics is proud to announce its support for Our Future Health, the UK’s largest ever health research programme. Eurofins Genomics will be genotyping five million...
Regulatory News: ANNEXE B Form to be used for the disclosure of the total number of voting rights and capital, in accordance with the law and grand-ducal regulation of 11 January 2008 on...
Regulatory News: Eurofins Scientific (Paris:ERF): Financial Highlights Eurofins delivered a very strong performance in FY 2021, exceeding all financial objectives: Record Revenues of €6,718m...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -1.5 | -2.65674814028 | 56.46 | 56.7 | 54.5 | 433987 | 55.38259974 | DE |
| 4 | 2.16 | 4.09090909091 | 52.8 | 58.24 | 51.98 | 396161 | 54.56075286 | DE |
| 12 | 6.56 | 13.5537190083 | 48.4 | 58.24 | 47.75 | 360417 | 52.96533731 | DE |
| 26 | -5.96 | -9.78332239002 | 60.92 | 62.1 | 39.47 | 399230 | 52.54106979 | DE |
| 52 | 2.64 | 5.04587155963 | 52.32 | 62.1 | 39.47 | 371923 | 53.38384972 | DE |
| 156 | -51.54 | -48.3943661972 | 106.5 | 118.12 | 39.47 | 390105 | 67.77876052 | DE |
| 260 | -400.04 | -87.9208791209 | 455 | 754 | 39.47 | 298986 | 84.79412965 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
